<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02583529</url>
  </required_header>
  <id_info>
    <org_study_id>14-0554</org_study_id>
    <nct_id>NCT02583529</nct_id>
  </id_info>
  <brief_title>Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation</brief_title>
  <acronym>NOVTPD</acronym>
  <official_title>Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tatiane Gomes de Araujo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dysfunctions of the lower urinary tract are non-motor symptoms common engines in Parkinson's
      disease (PD). Urodynamic changes in PD include overactive bladder (OB), characterized by
      urgency with or without urge incontinence , usually with frequency and nocturia . The aim of
      this study is to evaluate the efficacy and effectiveness of the treatment of OB in patients
      with PD with the use of a specific treatment: Posterior Tibial Nerve Electrostimulation
      (PTNE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Dysfunctions of the lower urinary tract are non-motor symptoms common engines
      in Parkinson's disease (PD). Urodynamic changes in PD include overactive bladder (OB),
      characterized by urgency with or without urge incontinence , usually with frequency and
      nocturia . The aim of this study is to evaluate the efficacy and effectiveness of the
      treatment of OB in patients with PD with the use of a specific treatment: Posterior Tibial
      Nerve Electrostimulation (PTNE). Materials and methods: This is test-clinical, double-blind,
      randomized, controlled comparison with placebo. The research will be conducted with patients
      diagnosed with PD and symptoms of OB in the Clinical Hospital of Porto Alegre, in the
      Movement Disorders and Urogynecology Ambulatories. The patients are divided into two groups,
      one of which receives placebo stimulation (often below the therapeutic threshold). They will
      be assessed before and after 12 weeks of treatment with home PTNE through specific form of
      questionnaires assessing incontinence, quality of life and voiding diary. After the end of
      treatment will be made up of patients to verify the effectiveness of treatment in 30 to 90
      days. Hypothesis: Through this research the investigators hope to determine the true efficacy
      of this treatment method with PTNE in OB in PD with a high level of evidence, seeking to
      improve urinary symptoms and quality of life in this patient population.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Voiding diary</measure>
    <time_frame>3 months</time_frame>
    <description>Consists of daily annotation fluid intake, frequency (number) and volume of urination (mL), daily activities and episodes of incontinence (number), need and number of hygienic protections, etc. It is a cost-effective method of initially assessing urinary complaints when compared to the test pad (pad test) and standardized symptom scales.The voiding diary will be filled before and after treatment that will last 03 months (baseline and 3 months). The patient will record your urinary habits for one day (24 hours) before starting treatment and after completion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hoehn and Yahr Disability Stage of scale</measure>
    <time_frame>3 months</time_frame>
    <description>Developed in 1967, called the DP indication of the general state of the patient. It comprises five phases (Table 1). On this scale, patients classified in stages 1, 2 and 3 show mild to moderate disability, while in stages 4 and 5 show more severe disability. HY is applied before treatment (baseline).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>King's Health Questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>The questionnaire presents 32 items distributed into 10 domains and is available in 26 languages. A change from baseline of 5 points (out of 100) in any field indicates significant clinical improvement. KHQ is applied before and after treatment (baseline and 3 months).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Overactive Bladder</condition>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Back Tibial Nerve Electrostimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>They will be assessed before and after 12 weeks of treatment with home PTNE through specific form of questionnaires assessing incontinence, quality of life and voiding diary. After the end of treatment will be made up of patients to verify the effectiveness of treatment in 30 to 90 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Electrostimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>They will be assessed before and after 12 weeks of treatment with home PTNE through specific form of questionnaires assessing incontinence, quality of life and voiding diary. After the end of treatment will be made up of patients to verify the effectiveness of treatment in 30 to 90 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Back Tibial Nerve Electrostimulation</intervention_name>
    <description>The BTNE will be made with electrodes Silver Spike Point (SSP) set in an ankle with the negative pole positioned on the inner malleolus and the positive approximately 05 cm below the previous, and connected to a portable stimulator powered by rechargeable battery developed by the Biomedical Engineering Department of the HCPA.</description>
    <arm_group_label>Back Tibial Nerve Electrostimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Electrostimulation</intervention_name>
    <description>The BTNPE will be made with electrodes Silver Spike Point (SSP) set in an ankle with the negative pole positioned on the inner malleolus and the positive approximately 05 cm below the previous, and connected to a portable stimulator powered by rechargeable battery developed by the Biomedical Engineering Department of the HCPA.</description>
    <arm_group_label>Placebo Electrostimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of PD according to the criteria of the London Brain Bank

          -  Complaint urinary storage symptoms such as urinary urgency (sudden urge, abrupt and
             imperious to urinate, which is difficult to be inhibited), with or without urge
             incontinence (urine leakage after emergency), frequency (number of urination&gt; 7 / day)
             and nocturia (the number of micturitions&gt; 1 / night).

        Exclusion Criteria:

          -  Damage to the peripheral sacral nerves

          -  Infection of the lower urinary tract untreated;

          -  Diabetes Mellitus;

          -  Chronic pulmonary disease worsened;

          -  Pregnancy and postpartum;

          -  Urinary Incontinence of pure stress incontinence or urinary Mixed with predominance of
             the stress component;

          -  Pacemaker or defibrillator;

          -  Metal prostheses;

          -  Application of botulinum toxin into the bladder and / or pelvic muscles last year;

          -  Current TENS treatment in the pelvic region, lower back and / or legs;

          -  Prior Urinary incontinence surgery;

          -  Current bladder carcinoma;

          -  Cognitive impairment likely to prevent implementation of the proposed treatment;

          -  Not understand / sign informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Geraldo Lopes Ramos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Rio Grande do Sul</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tatiane Gomes de Araujo, Brazil</last_name>
    <phone>51 82086083</phone>
    <email>tatinhaga@yahoo.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tatiane Gomes de Araujo</last_name>
    <phone>51 33645021</phone>
    <email>tatinhaga@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tatiane Gomes de Araujo</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90035-052</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatiane Gomes de Araujo</last_name>
      <phone>51 82086083</phone>
    </contact>
    <contact_backup>
      <last_name>Tatiane Gomes de Araujo</last_name>
      <phone>51 33645021</phone>
    </contact_backup>
    <investigator>
      <last_name>Jos√© Geraldo Lopes Ramos</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlor Roberto de Mello Rieder</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pedro Schestatsky</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana Prato Schmidt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulo Roberto Stefani Sanches</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danton Pereira da Silva Jr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2015</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Clinicas de Porto Alegre</investigator_affiliation>
    <investigator_full_name>Tatiane Gomes de Araujo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>Neurogenic Overactive Bladder</keyword>
  <keyword>Posterior Tibial Nerve Electrostimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

